Clinical trial · Interventional
CDSS-assisted UGI Endoscopy vs. Routine Screening Endoscopy
Clinical Benefit in the CDSS-assisted Screening Upper Gastrointestinal Endoscopy vs. Routine Screening Endoscopy
NCT05452473CI-TRIAL-00059627unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to find the CDSS-assisted upper GI endoscopy has clinical benefit compared to conventional routine screening upper GI endoscopy. Investigators will conduct a pilot randomized controlled study. Consecutive patients will be allocated either to CDSS-assisted upper GI endoscopy or conventional routine screening upper GI endoscopy. The lesion detection rate will be compared between both groups.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Healthy Individual | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CDSS-assisted upper GI endoscopy | Other | — | UNRESOLVED |
| no intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- CDSS-assisted screening endoscopy
- description
- Participants will be tested for CDSS-assisted screening upper gastrointestinal endoscopy
- interventionNames
- Other: CDSS-assisted upper GI endoscopy
- type
- PLACEBO_COMPARATOR
- label
- Conventional routine screening endoscopy
- description
- Participants will be tested for Conventional routine screening upper gastrointestinal endoscopy
- interventionNames
- Other: no intervention
Primary outcomes (1)
- measure
- Gastric lesion detection rate
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Participants who visited for routine screening upper gastrointestinal endoscopy Exclusion Criteria: * Participants who refuse to participate in this study * Participants who showed paradoxical reaction prohibiting routine examination
References
Publications (1)
- DERIVEDGong EJ, Bang CS, Lee JJ, Baik GH, Lim H, Jeong JH, Choi SW, Cho J, Kim DY, Lee KB, Shin SI, Sigmund D, Moon BI, Park SC, Lee SH, Bang KB, Son DS. Deep learning-based clinical decision support system for gastric neoplasms in real-time endoscopy: development and validation study. Endoscopy. 2023 Aug;55(8):701-708. doi: 10.1055/a-2031-0691. Epub 2023 Feb 8. PMID 36754065